Business Wire

Lenovo ranks 10th in the Gartner® Supply Chain Top 25 for 2024 report

Share

Lenovo has once again been ranked in the Gartner Supply Chain Top 25 for 2024, ranking tenth in this list of global companies with exceptional supply chains. The Gartner Supply Chain Top 25 is a renowned annual ranking of the world’s superior supply chains. From financial and corporate social responsibility data and community opinion, the Gartner Supply Chain Top 25 for 2024 report, celebrates and profiles companies demonstrating excellence in supply chain management.

Over the last 12 months, Lenovo has intensified its focus on key areas in its supply chain, including security, digital transformation, and environmental sustainability, alongside the company’s global/local approach to drive greater efficiencies and improved customer outcomes.

Today, Lenovo’s global hybrid manufacturing network includes 30+ manufacturing sites spanning 10 markets in the 180 markets Lenovo does business in, including Argentina, Brazil, China, Germany, Hungary, India, Japan, Mexico, and the US. This ensures the supply chain remains resilient and can adapt to any disruption.

Lenovo’s supply chain is one of the clearest examples of its global/local strategy and delivers not only operational efficiencies for the business but a definitive advantage to customers through a focus on manufacturing in Europe for Europe, the Americas for the Americas, and Asia for Asia. Bringing manufacturing closer to customers shortens the local supply chain, utilizes the local skilled labor force, and supports Lenovo's sustainability goals through more sustainable manufacturing methods. Building devices close to customers dramatically reduce the freight miles these products incur, providing more efficient and sustainable transportation options. As an example, since becoming operational in 2022, Lenovo’s European manufacturing facility in Hungary has shipped over 1.5 million workstations and servers to over 2,500 customers in 70 markets across EMEA.

Che Min (Jammi) Tu, Senior Vice President and Group Operations Officer, Lenovo, said, “Our supply chain has always been a towering strength for Lenovo and remains fundamental to our future success. Over the past few years, we’ve seen the topic of supply chains make headlines around the world when the flow of goods is impacted and the knock-on effect this has on a business and its reputation. What’s clearer than ever today is that a company’s supply chain is a competitive advantage and can no longer be considered a cost center. In fact, at Lenovo, we’ve successfully transitioned our global supply chain into a commercial center and profit pool. We are also pioneering Manufacturing as a Service, as well as developing and incubating new technologies and solutions within our manufacturing facilities and logistics services that we can offer our customers. For us, we’re incredibly proud that we continue to be recognized as having one of the most exceptional supply chains in the world across all industries.”

Lenovo's commitment to delivering innovation, efficiency, and resilience to customers worldwide is underpinned by its resilient supply chain, ensuring cutting-edge products reach customers securely.

Lenovo's supply chain security approach is built on a foundation of prevention. Suppliers and components are vigorously vetted, with the company’s security-by-design approach embedded into the product lifecycle. By taking a proactive stance against backdoors, tainted products, counterfeits, and hardware/software vulnerabilities, Lenovo safeguards its products and sets a high industry standard for supply chain security.

Doug Fisher, SVP and Chief Security Officer, Lenovo, said, “Lenovo is dedicated to driving supply chain security through leadership, so we remain in front of the supply chain evolution. Our goal is to ensure our products are safe, highly resilient, and trustworthy before entering our customers’ environment. We attest to the integrity of each device right down to the lowest levels in the system.”

Lenovo also remains committed to ESG. It was in the first group of companies and the first PC and smartphone maker to have targets validated in alignment to Science Based Targets initiative’s Net-Zero Standard. It continues to focus on future-proofing its operations by making the supply chain more robust, adaptable, and profitable and recently released Lenovo ESG Navigator, a digital solution for collecting and measuring ESG data points – like energy use - from factory sites in real time.

With the development of an AI-powered ESG assessment system such as Lenovo’s Intelligence Sustainability Solutions Advisor (LISSA), Lenovo is empowering customers with actionable sustainability insights from across the global supply chain to understand the estimated emissions impact across their IT lifecycle and make critical decisions to decrease emissions. Initially developed to support supply chain decision-making, LISSA has now been commercially deployed to support customers’ IT sustainability goals.

As part of Lenovo’s drive towards the circular economy, utilizing the supply chain for customers’ after-sales support, where possible, returned components are repaired by engineers, quality-tested, and reused. To date, 4m+ components, including motherboards, processors, drives, memory, and more, have been diverted from landfills for reuse within the product lifecycle.

About the Gartner Supply Chain Top 25 ranking and methodology

The Supply Chain Top 25 ranking comprises two main components: business performance and opinion. Business performance in the form of public financial and ESG (environmental, social, governance) data provides a view into how companies have performed in the past three years, while the opinion component offers an eye to future potential and reflects leadership in the supply chain community. These two components are combined into a total composite score.

Gartner derives a list of companies from a combination of the Fortune Global 500 and the Forbes Global 2000. In an effort to maintain the list of companies evaluated at a manageable level, a general annual revenue threshold of $15 billion has been applied and companies without physical supply chains are excluded.

Read the full Gartner Supply Chain Top 25 for 2024 Report here.

Gartner Press Release: Gartner Announces 20th Annual Rankings of the Global Supply Chain Top 25, May 22, 2024.

Gartner Insights, The Gartner Supply Chain Top 25 for 2024, https://www.gartner.com/en/supply-chain/research/supply-chain-top-25.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

About Lenovo

Lenovo is a US$57 billion revenue global technology powerhouse, ranked #217 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a pocket-to cloud portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Stuart Gill
Director of Global Media Relations, Campaigns, and Corporate Content
Corporate Marketing Group +44 (0)7917 437 532
sgill@lenovo.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia23.6.2024 05:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today presented positive results from its Phase 2b, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability and efficacy of mezagitamab (TAK-079) in patients with persistent or chronic primary immune thrombocytopenia (ITP), a rare immune-mediated bleeding disorder. ITP is characterized by the accelerated destruction of platelets in blood, resulting in a decreased platelet count and an increase of bleeding that can be debilitating. These data (Abstract #LB 01.1) were presented at the oral Late-Breakthrough Session at the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Bangkok, Thailand. Takeda plans to initiate a global Phase 3 trial of mezagitamab in patients with ITP in the second half of FY2024. The TAK-079-1004 trial (NCT04278924) evaluated three different doses of subcutaneous mezagitamab (100mg, 300mg and 600mg) versus placebo, given once weekly for eight weeks in patients with chronic or

PMC Biogenix Announces Expansion and Restructure22.6.2024 00:00:00 EEST | Press release

PMC Biogenix, the leading sustainable producer of specialty fatty amides and high-value biobased products, announces the construction and expansion of its new Armoslip® facility in Gyeongju, South Korea allowing for a production capacity increase of 50%. Construction will begin late 2024 with new supply available by mid-2026. “We are excited to announce plans to build a new facility in Gyeongju. This investment will allow us to significantly increase production capacity to meet growing customer demand for our Armoslip products,” said Debtosh Chakrabarti, President, PMC Group N.A., Inc. Adding, “This project solidifies our commitment as the industry leader, delivering products and solutions to our customers, as well as to the local Gyeongju community. We appreciate the continued support of the Gyeongju, South Korea local government, community, and our customers.” As part of PMC’s ongoing commitment of ensuring long-term sustainability and success of the Biogenix business world-wide, a c

Esri Technology Used By ALS Therapy Development Institute to Map Clinical Trials21.6.2024 23:58:00 EEST | Press release

The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech dedicated to ending amyotrophic lateral sclerosis (ALS), has used mapping technology from Esri, the global leader in location intelligence, to develop the ALS Trial Navigator. The new tool is designed to simplify and streamline the process by which people with ALS and their caretakers learn about current ALS studies. With the ALS Trial Navigator users can now explore an interactive map to find locations where applicable clinical trials are taking place. They can also receive a customized map based on their preferences and status of their ALS. "ALS Trial Navigator helps people living with ALS, those that might face it in the future, and researchers looking to enroll trials by educating the community and providing information about current studies all around the world," said Dr. Nadia Sethi, ALS TDI's director of community engagement, who oversaw the Navigator's design and creation. Once a person is diagnosed with ALS,

Lifezone Metals Announces Voting Results from its 2024 Annual General Meeting21.6.2024 23:30:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) announces the results of voting by shareholders at its 2024 Annual General Meeting (the “AGM”) held today in the Isle of Man. The ordinary resolutions below were passed by shareholders, with voting results as follows: Ordinary Resolutions For % For Against % Against Abstain % Abstain To receive the Company’s accounts for the financial year ended December 31, 2023 60,456,134 100.00% 0 0.00% 264 0.00% To re-elect John Dowd as a Class I Director of the Company 60,375,930 99.87% 79,177 0.13% 1,291 0.00% To re-elect Govind Friedland as a Class I Director of the Company 59,713,208 98.77% 79,319 0.13% 663,871 1.10% To re-elect Ambassador Mwanaidi Maajar as a Class I Director of the Company 60,314,469 99.77% 81,886 0.14% 60,043 0.10% A total of 60,456,398 or 75.57% of Lifezone Metals Ordinary Shares outstanding were represented at the AGM. If you would like to sign up for Lifezone Metals news alerts, please register here. About Lifezone Metals At Lifezone Me

Takeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal Cancer21.6.2024 23:00:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) approved FRUZAQLA (fruquintinib) as a monotherapy indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with available standard therapies, including fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapies, anti-VEGF agents, and anti-EGFR agents, and who have progressed on or are intolerant to treatment with either trifluridine-tipiracil or regorafenib. The decision follows a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) on April 25, 2024, and approval by the U.S. Food and Drug Administration (FDA) for adults with mCRC who have been previously treated with oxaliplatin- and irinotecan-based regimens on November 8, 2023.1,2 “People living with metastatic colorectal cancer face numerous difficulties, stemming both from their illness and the adverse effects of therapies. Given the complex nature of the d

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye